Compare Agilent Technologies Inc (A) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Tesla, Inc. — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Tesla, Inc. trades at $332.41 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 31.2× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| A | TSLA | |
|---|---|---|
Market Cap | $42.00B | $1.31T |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $489.88 |
52-Week Low | $110.24 | $298.16 |
Enterprise Value | $43.55B | $1.28T |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Tesla (TSLA) trades at $330.87, up 0.7% today, amid mixed signals: technicals are bearish with support at $327 and resistance at $333, while fundamentals show elevated valuation ratios (P/E 306.37) but recent earnings beats. Revenue dipped to $94.83B in 2025, with net margin at 3.67%, as the company pivots toward AI and robotics. News highlights regulatory approval for self-driving software in Europe (Reuters, 2026-04-10) and a 315% surge in German registrations (Zacks, 2026-04-10).
Outlook: Tesla's stock faces headwinds from high valuation and slowing auto growth, but opportunities exist in AI and energy expansion. Risks include intense EV competition and execution challenges. Analysts are divided, with a consensus price target of $393.87 (40.74% buy ratings), suggesting cautious optimism if innovation delivers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
